Largest pharmaceutical companies by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Veradermics has the lowest figure of the 61 pharmaceutical companies ranked by total assets, at HUF 51.3B, followed by Erasca (HUF 133.1B) and Definium Therapeutics (HUF 147.9B). Figures as of 18 Nov 2026, 21:08 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- Lowest
- VeradermicsHUF 51.3B
- Median
- HUF 1.18T
- Combined market value
- HUF 1700.18T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total assets ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | VeradermicsMANE · Health Care | HUF 51.3B | HUF 1.77T | HUF 41,975.96 | 0.59% down | 233% up | ||
| 2 | ErascaERAS · Health Care | HUF 133.1B | HUF 1.62T | HUF 4,624.60 | 0.94% down | 403% up | ||
| 3 | Definium TherapeuticsDFTX · Health Care | HUF 147.9B | HUF 1.34T | HUF 9,786.94 | 0.88% down | 169% up | ||
| 4 | Rhythm PharmaceuticalsRYTM · Health Care | HUF 161.4B | HUF 2.77T | HUF 40,008.15 | 2.08% up | 13% up | ||
| 5 | Oruka TherapeuticsORKA · Health Care | HUF 164.2B | HUF 2.18T | HUF 32,177.26 | 0.60% down | 241% up | ||
| 6 | Dianthus TherapeuticsDNTH · Health Care | HUF 178.4B | HUF 1.59T | HUF 28,224.84 | 3.45% down | 113% up | ||
| 7 | Edgewise TherapeuticsEWTX · Health Care | HUF 185.7B | HUF 1.52T | HUF 13,904.04 | 1.59% down | 88% up | ||
| 8 | Travere TherapeuticsTVTX · Health Care | HUF 203.4B | HUF 1.62T | HUF 16,885.16 | 1.68% down | 44% up | ||
| 9 | ABIVAXABVX · Health Care | HUF 217.9B | HUF 2.47T | HUF 28,174.42 | 2.11% up | 27% down | ||
| 10 | Protagonist TherapeuticsPTGX · Health Care | HUF 224.6B | HUF 2.79T | HUF 42,737.20 | 2.00% up | 46% up | ||
| 11 | Axsome TherapeuticsAXSM · Health Care | HUF 231.8B | HUF 2.37T | HUF 45,036.06 | 1.43% down | 7% down | ||
| 12 | Summit TherapeuticsSMMT · Health Care | HUF 252.5B | HUF 2.82T | HUF 3,528.94 | 1.59% down | 36% down | ||
| 13 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | HUF 256.6B | HUF 2.51T | HUF 31,945.35 | 0.06% down | 126% up | ||
| 14 | Spyre TherapeuticsSYRE · Health Care | HUF 261.4B | HUF 3.24T | HUF 34,099.69 | 8.15% up | 286% up | ||
| 15 | Belite BioBLTE · Health Care | HUF 262.3B | HUF 2.13T | HUF 52,507.34 | 0.94% down | 31% up | ||
| 16 | Corcept TherapeuticsCORT · Health Care | HUF 281.2B | HUF 2.49T | HUF 22,783.54 | 3.25% down | 8% down | ||
| 17 | Mirum PharmaceuticalsMIRM · Health Care | HUF 283.3B | HUF 2.03T | HUF 31,084.96 | 0.59% up | 31% up | ||
| 18 | BridgeBio PharmaBBIO · Health Care | HUF 314.6B | HUF 5.11T | HUF 26,218.38 | 1.58% up | 17% up | ||
| 19 | Cogent BiosciencesCOGT · Health Care | HUF 315.1B | HUF 1.63T | HUF 9,346.66 | 0.14% down | 20% down | ||
| 20 | Praxis Precision MedicinesPRAX · Health Care | HUF 315.2B | HUF 2.87T | HUF 102,571.31 | 0.04% up | 61% up | ||
| 21 | TG TherapeuticsTGTX · Health Care | HUF 357.3B | HUF 3.36T | HUF 22,222.27 | 5.44% up | 107% up | ||
| 22 | Madrigal PharmaceuticalsMDGL · Health Care | HUF 423.3B | HUF 3.11T | HUF 133,790.71 | 5.67% down | 24% down | ||
| 23 | Arrowhead PharmaceuticalsARWR · Health Care | HUF 465.6B | HUF 2.05T | HUF 14,488.84 | 0.28% up | 10% up | ||
| 24 | CytokineticsCYTK · Health Care | HUF 478.8B | HUF 2.4T | HUF 17,248.14 | 0.64% down | 20% down | ||
| 25 | Ascendis PharmaASND · Health Care | HUF 485.7B | HUF 5.96T | HUF 90,855.21 | 0.32% down | 28% up | ||
| 26 | Ligand PharmaceuticalsLGND · Health Care | HUF 524.5B | HUF 2.01T | HUF 100,393.44 | 1.67% up | 43% up | ||
| 27 | Legend BiotechLEGN · Health Care | HUF 582.7B | HUF 1.06T | HUF 5,461.46 | 0.87% up | 42% down | ||
| 28 | InsmedINSM · Health Care | HUF 761.1B | HUF 8.83T | HUF 40,263.58 | 1.69% down | 40% down | ||
| 29 | AlkermesALKS · Health Care | HUF 835.9B | HUF 2.65T | HUF 15,745.82 | 3.08% up | 58% up | ||
| 30 | PTC TherapeuticsPTCT · Health Care | HUF 974.2B | HUF 1.69T | HUF 20,242.70 | 0.22% down | 20% down | ||
| 31 | Ionis PharmaceuticalsIONS · Health Care | HUF 1.18T | HUF 1.53T | HUF 9,205.51 | 1.59% up | 64% down | ||
| 32 | Amneal PharmaceuticalsAMRX · Health Care | HUF 1.24T | HUF 2.56T | HUF 7,353.65 | 3.60% up | 83% up | ||
| 33 | Alnylam PharmaceuticalsALNY · Health Care | HUF 1.67T | HUF 6.73T | HUF 50,211.85 | 4.54% down | 66% down | ||
| 34 | Roivant SciencesROIV · Health Care | HUF 1.92T | HUF 9.43T | HUF 13,016.77 | 0.05% up | 90% up | ||
| 35 | Dr. Reddy's LaboratoriesRDY · Health Care | HUF 2.07T | HUF 4.2T | HUF 5,034.63 | 1.28% up | 5% up | ||
| 36 | BioMarin PharmaceuticalBMRN · Health Care | HUF 2.55T | HUF 4T | HUF 20,646.01 | 4.99% up | 11% up | ||
| 37 | United TherapeuticsUTHR · Health Care | HUF 2.65T | HUF 8.26T | HUF 194,038.20 | 1.16% down | 23% up | ||
| 38 | BeOne MedicinesONC · Health Care | HUF 2.75T | HUF 15.49T | HUF 135,645.92 | 2.34% down | 17% up | ||
| 39 | Jazz PharmaceuticalsJAZZ · Health Care | HUF 3.92T | HUF 5.35T | HUF 83,273.02 | 2.93% up | 37% up | ||
| 40 | GenmabGMAB · Health Care | HUF 4.33T | HUF 10.56T | HUF 17,130.51 | 1.91% down | 70% up | ||
| 41 | Elanco Animal HealthELAN · Health Care | HUF 4.49T | HUF 4.48T | HUF 8,970.24 | 3.25% up | 20% up | ||
| 42 | ZoetisZTS · Health Care | HUF 5.2T | HUF 11.69T | HUF 28,759.56 | 2.50% up | 29% down | ||
| 43 | Royalty PharmaRPRX · Health Care | HUF 6.59T | HUF 13.27T | HUF 23,079.30 | 0.01% down | 78% up | ||
| 44 | GrifolsGRFS · Health Care | HUF 7.35T | HUF 1.94T | HUF 2,846.68 | 1.85% down | 1% up | ||
| 45 | Vertex PharmaceuticalsVRTX · Health Care | HUF 8.62T | HUF 45.71T | HUF 180,295.48 | 0.42% up | 27% up | ||
| 46 | ViatrisVTRS · Health Care | HUF 12.5T | HUF 7.81T | HUF 6,815.91 | 0.83% down | 96% up | ||
| 47 | Regeneron PharmaceuticalsREGN · Health Care | HUF 13.63T | HUF 32.87T | HUF 317,783.18 | 1.28% down | 36% up | ||
| 48 | Teva Pharmaceutical IndustriesTEVA · Health Care | HUF 13.69T | HUF 16.55T | HUF 14,184.34 | 0.98% down | 74% up | ||
| 49 | Novo NordiskNVO · Health Care | HUF 27.08T | HUF 58.44T | HUF 13,258.75 | 3.07% down | 17% down | ||
| 50 | GSKGSK · Health Care | HUF 27.27T | HUF 32.73T | HUF 16,327.25 | 1.34% down | 6% up | ||
| 51 | Abbott LaboratoriesABT · Health Care | HUF 29.14T | HUF 60.82T | HUF 35,118.04 | 0.21% down | 17% down | ||
| 52 | Bristol-Myers SquibbBMY · Health Care | HUF 30.26T | HUF 40.92T | HUF 20,017.52 | 2.92% down | 34% up | ||
| 53 | Takeda PharmaceuticalTAK · Health Care | HUF 32.65T | HUF 22.84T | HUF 7,150.31 | 1.69% down | 54% up | ||
| 54 | NovartisNVS · Health Care | HUF 37.29T | HUF 98.55T | HUF 52,181.33 | 2.43% down | 25% up | ||
| 55 | Eli LillyLLY · Health Care | HUF 37.8T | HUF 413.82T | HUF 464,582.25 | 2.35% down | 35% up | ||
| 56 | AstraZenecaAZN · Health Care | HUF 38.34T | HUF 93.18T | HUF 60,082.81 | 1.92% down | 2% up | ||
| 57 | AbbVieABBV · Health Care | HUF 45.02T | HUF 169.88T | HUF 96,108.30 | 2.34% down | 26% up | ||
| 58 | Merck & CoMRK · Health Care | HUF 46T | HUF 114.13T | HUF 46,296.40 | 3.92% down | 51% up | ||
| 59 | SanofiSNY · Health Care | HUF 47.28T | HUF 38.03T | HUF 15,836.56 | 0.86% down | 4% down | ||
| 60 | Johnson & JohnsonJNJ · Health Care | HUF 66.95T | HUF 220.65T | HUF 91,658.46 | 2.15% down | 38% up | ||
| 61 | PfizerPFE · Health Care | HUF 69.96T | HUF 53.75T | HUF 9,430.72 | 1.44% down | 14% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 336.1 HUF).
Questions and answers
Which pharmaceutical companies have the lowest total assets?
Veradermics (HUF 51.3B), Erasca (HUF 133.1B) and Definium Therapeutics (HUF 147.9B) have the lowest total assets of the 61 pharmaceutical companies ranked here as of 18 Nov 2026, 21:08 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by total assets.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by total assets have a combined market value of HUF 1700.18T as of 18 Nov 2026, 21:08 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies by total assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.